The U.S. hemp boom, fueled by the 2018 Farm Bill, faces collapse under new rules imposing strict Total THC limits by 2026. Many products could vanish....
Europe’s medical cannabis market has expanded rapidly through telemedicine, e-prescriptions, and mail-order pharmacies, especially in Germany. This growth has improved patient access but raised political concerns...
Germany’s medical cannabis market is expanding, with over 50 tons imported in early 2026, making it Europe’s leading market. Reforms improved patient access and boosted demand,...
Two years after partial cannabis legalization in Germany, results are mixed. Medical cannabis is booming and many consumers are decriminalized, but social clubs face heavy bureaucracy,...
France is tightening “novel food” rules on CBD edibles, threatening gummies, drinks, and supplements. This stricter stance could ripple across Europe, disrupting supply chains and raising...
In 2026, global cannabis laws fall into four categories: strict prohibition, decriminalization, partial legalization, and fully regulated markets, with only Canada, Uruguay, and parts of the...
Germany’s cannabis law legalized adult possession and cultivation in 2024, introducing regulated social clubs. In Mecklenburg-Western Pomerania, only a few clubs operate amid strict bureaucracy. The...
Agential Cannabis 2026 will take place September 23–24 in Bangkok, bringing global experts together to advance the APAC medical cannabis market. As the region shifts to...
The U.S. has reclassified cannabis from Schedule I to Schedule III, recognizing its medical use and easing research restrictions. The change reduces tax burdens for cannabis...
Cannabis stocks, including Tilray, plunged after a 2021 speculative peak, remaining in long-term decline. Momentum may shift as U.S. authorities consider reclassifying cannabis. Tilray shows technical...